AKR1C1 and acute lymphoblastic leukemia: This sensitisation effect was obtained by the specific inhibition of AKR1C1-3, without the need to counteract additional detoxifying genes, generally regulated by NRF2, thus indicating a major role of AKR1C family members in modulating drug response in T-ALL.